Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection

INTRODUCTION: Achieving functional cure of chronic HBV infection (Hepatitis B surface antigen [HBsAg] clearance, eventually followed by acquisition of anti-hepatitis B surface antigen [Anti-HBs]) in individuals with HIV and HBV infections is a rare event. In this setting, factors related to HBV cure...

Descripción completa

Detalles Bibliográficos
Autores principales: Gantner, Pierre, Cotte, Laurent, Allavena, Clotilde, Bani-Sadr, Firouzé, Huleux, Thomas, Duvivier, Claudine, Valantin, Marc-Antoine, Jacomet, Christine, Joly, Véronique, Chéret, Antoine, Pugliese, Pascal, Delobel, Pierre, Cabié, André, Rey, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472771/
https://www.ncbi.nlm.nih.gov/pubmed/30998789
http://dx.doi.org/10.1371/journal.pone.0215464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472771/
https://www.ncbi.nlm.nih.gov/pubmed/30998789
http://dx.doi.org/10.1371/journal.pone.0215464

Ejemplares similares